Replies to post #4457 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

bladerun, I would expect that Merck will look at their preliminary results for the following indications before getting out the check book:

Breast cancer
Endometrial cancer
Prostate cancer
Non-small cell lung cancer
Sarcomas (Japan)
Other solid tumors
Pediatrics

I would...wouldn't you??